Overview
The purpose of this study is to evaluate patient-reported post-operative pain scores following minimally invasive tubal sterilization procedures to determine if a multimodal, non-opioid pain control regimen is non-inferior to a pain control regimen including opioids.
The study team hypothesizes that with extensive counseling on pain management, multimodal medication use, and expectation with non-opioid methods can effectively eliminate the need for opioid prescriptions after laparoscopic salpingectomy.
Eligibility
Inclusion Criteria:
- Individuals with a fallopian tube (unilateral and/or bilateral)
- Age 18 years old and above
- Undergoing minimally invasive (laparoscopic or robotic) unilateral or bilateral salpingectomy or other tubal sterilization procedure as the primary procedure
- Benign indications for salpingectomy/tubal sterilization
- Agreeing to participate
Exclusion Criteria:
- Chronic pain syndromes patients including fibromyalgia
- Patients currently on long-term (i.e. for more than three months) opioid use
- Conversion to laparotomy
- Allergy or other contraindication to the prescribed medications such as acetaminophen or oxycodone
- Salpingectomy that occurs in conjunction with a major Gyn surgery (i.e. hysterectomy, etc)
- Salpingectomy performed for treatment of ectopic pregnancy
- Patients with a history of gastritis and/or GI bleeding